Vytrus Biotech, S.A. (BME:VYT)
Spain
· Delayed Price · Currency is EUR 4.080
+0.360 (9.68%)
At close: Jun 6, 2025, 5:30 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €30.77 million as of June 6, 2025. Its market cap has increased by 88.75% in one year.
Market Cap
30.77M
Enterprise Value
30.57M
Revenue
5.24M
Ranking
n/a
PE Ratio
44.15
Stock Price
€4.08
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 30.77M, an increase of 100.18%. That is a compound annual growth rate of 23.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 30.77M | 88.89% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.31B |
| Laboratorios Farmaceuticos Rovi | 2.82B |
| Almirall | 2.41B |
| Pharma Mar | 1.62B |
| Faes Farma | 1.33B |
| Clínica Baviera | 654.63M |
| Laboratorio Reig Jofre | 259.39M |
| Oryzon Genomics | 224.79M |